Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 5—May 2024
Research

Analysis of Suspected Measles Cases with Discrepant Measles-Specific IgM and rRT-PCR Test Results, Japan

Yumani Kuba1Comments to Author , Minoru Nidaira, Noriyuki Maeshiro, Katsuhiro Komase, Hajime Kamiya, and Hisako Kyan
Author affiliations: Okinawa Prefectural Institute of Health and Environment, Okinawa, Japan (Y. Kuba, M. Nidaira, N. Maeshiro, H. Kyan); National Institute of Infectious Diseases, Tokyo, Japan (K. Komase, H. Kamiya)

Main Article

Figure 2

Measles-specific antibody titers and febrile exanthematous viral gene detection results in an analysis of suspected measles cases with discrepant measles-specific IgM and rRT-PCR test results, Japan. Figure represents 24 cases with measles-specific IgM-positive and rRT-PCR–negative results. White circles represent cases in children <1 year to 4 years of age with >1 doses of measles-containing vaccine; black circles represent cases in adults with unknown vaccination history. CMV, cytomegalovirus; HHV-6, human herpesvirus 6; HHV-7, human herpesvirus 7; HPeV, human parechovirus; multiple, multiple pathogens were detected; ND, not detected.

Figure 2. Measles-specific antibody titers and febrile exanthematous viral gene detection results in an analysis of suspected measles cases with discrepant measles-specific IgM and rRT-PCR test results, Japan. Figure represents 24 cases with measles-specific IgM-positive and rRT-PCR–negative results. White circles represent cases in children <1 year to 4 years of age with >1 doses of measles-containing vaccine; black circles represent cases in adults with unknown vaccination history. CMV, cytomegalovirus; HHV-6, human herpesvirus 6; HHV-7, human herpesvirus 7; HPeV, human parechovirus; multiple, multiple pathogens were detected; ND, not detected.

Main Article

1Current affiliation: Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan.

Page created: March 14, 2024
Page updated: April 23, 2024
Page reviewed: April 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external